Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes page

Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes

The present invention provides compositions and methods for treating glaucoma, ocular hypertension, and age-related macular degeneration. More specifically, the present invention describes the use of agents that down-regulate expression of tanis and/or p21.sup.Waf1/Cip1/Sd1 genes to treat such disorders of the eye.

Web www.patentalert.com

< Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determining single nucleotide polymorphisms

< Allomone repulsive and kairomone attractive compositions for controlling arachnids

> Agents for intravitreal administration to treat or prevent disorders of the eye

> Novel compounds

~ 00189